CERUS CORP (CERS)
Latest CERS Insider Trades
- Chrystal Jensen - OfficerOpen-market sale$90K
Vivek K. Jayaraman - Officer
About CERUS CORP (CERS)
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.
- CONCORD, CA
- 345
- 1997
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 8 | 286,070 | $841K |
| Grant or award | 12 | 1,675,315 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
CERS Insider Transactions (Form 4)
4443 Form 4 filings on record, the earliest from Dec 16, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Chrystal Jensen - Officer | Open-market sale | Common Stock | 30,000 |
Recent CERS Form 8-K Filings
5Recent CERS Form 144 Notices of Proposed Sale
3A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| CHRYSTAL NIKOLE JENSEN | Officer | 30,000 | $90K | View on EDGAR | |
| - | - |
CERS Insider Trading - FAQ
What is the latest insider trade for CERS?
CERUS CORP (CERS) had 14 insider filings in the last 90 days, with the most recent on 2026-08-18. The full record for CERS runs to 43 Form 4 filings, the earliest from 2024-12-16. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying CERS stock?
No insider purchases of CERS were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling CERS stock?
8 insider sales of CERS were filed in the last 90 days, totaling $841K.
Where can I see CERS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks CERS Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow CERS insider buys?
Create a free InsiderAlpha account and press Watch on this page to add CERS to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Chrystal Jensen view on EDGAR
- - Vivek K. Jayaraman view on EDGAR
- - Kevin Dennis Green view on EDGAR
- - Vivek K. Jayaraman view on EDGAR
- - Chrystal Jensen view on EDGAR
- - William Mariner Greenman view on EDGAR
- - Eric Bjerkholt view on EDGAR
- - Ann Lucena view on EDGAR
- - Eric Bjerkholt view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where CERS's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track CERS insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
